313 related articles for article (PubMed ID: 16673210)
21. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis.
Safarinejad MR
J Neuroendocrinol; 2008 Dec; 20(12):1368-75. PubMed ID: 19094084
[TBL] [Abstract][Full Text] [Related]
23. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
Helgason S
Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
[TBL] [Abstract][Full Text] [Related]
24. [Sex hormone changes in male epileptics on long-term anti-convulsant therapy (author's transl)].
Hoffmann H; Kahlert T
Nervenarzt; 1981 Dec; 52(12):715-7. PubMed ID: 6798479
[No Abstract] [Full Text] [Related]
25. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
26. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
[TBL] [Abstract][Full Text] [Related]
27. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
Franke HR; Smit WM; Vermes I
Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
[TBL] [Abstract][Full Text] [Related]
28. Biologic effects of transdermal estradiol.
Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency.
Giavoli C; Ferrante E; Ermetici F; Bergamaschi S; Ronchi CL; Lania AG; Ambrosi B; Spada A; Beck-Peccoz P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):717-21. PubMed ID: 17121521
[TBL] [Abstract][Full Text] [Related]
30. Effects of estradiol infusion in GnRH immunized boars on spermatogenesis.
Wagner A; Messe N; Bergmann M; Lekhkota O; Claus R
J Androl; 2006; 27(6):880-9. PubMed ID: 16870949
[TBL] [Abstract][Full Text] [Related]
31. Testicular and blood steroid levels in aged men.
Carreau S; Bourguiba S; Marie E
Reprod Biol; 2004 Nov; 4(3):299-304. PubMed ID: 15592588
[TBL] [Abstract][Full Text] [Related]
32. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
[TBL] [Abstract][Full Text] [Related]
33. Triphasic pills: variability of endocrine parameters and of sex steroid-binding globulins.
Pasinetti E; Falsetti L
Acta Eur Fertil; 1993; 24(2):67-70. PubMed ID: 8171924
[TBL] [Abstract][Full Text] [Related]
34. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
[TBL] [Abstract][Full Text] [Related]
35. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
Pathak AS; Pacificar JS; Shapiro CE; Williams SG
J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
[TBL] [Abstract][Full Text] [Related]
36. Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.
Lundgren S; Helle SI; Lonning PE
Clin Cancer Res; 1996 Sep; 2(9):1515-21. PubMed ID: 9816328
[TBL] [Abstract][Full Text] [Related]
37. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
38. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
39. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Rose DP; Davis TE
Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282
[TBL] [Abstract][Full Text] [Related]
40. Plasma levels of estrogen, luteinizing hormone, and follicle stimulating hormone following castration and estradiol implant.
Hunter DJ; Julier D; Franklin M; Green E
Obstet Gynecol; 1977 Feb; 49(2):180-5. PubMed ID: 834401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
